Bionik Laboratories Corp.
BNKL · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $427 | $685 | $398 | $1,329 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $453 | $337 | $581 | $119 |
| Inventory | $1,034 | $1,144 | $1,351 | $1,419 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $2,778 | $3,075 | $3,233 | $3,923 |
| Property Plant & Equip (Net) | $442 | $466 | $454 | $80 |
| Goodwill | $100 | $100 | $100 | $0 |
| Intangibles | $34 | $35 | $36 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $9 | $8 | -$80 |
| Total NC Assets | $585 | $610 | $597 | $80 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,362 | $3,685 | $3,830 | $4,003 |
| Liabilities | – | – | – | – |
| Payables | $558 | $381 | $352 | $427 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $342 | $397 | $453 | $247 |
| Other Curr. Liab. | $291 | $0 | $0 | $0 |
| Total Curr. Liab. | $2,309 | $2,092 | $2,032 | $1,692 |
| LT Debt | $2,156 | $1,842 | $1,017 | $503 |
| Deferred Rev, NC | $303 | $274 | $258 | $211 |
| Deferred Tax Liab, NC | $0 | $1,601 | $771 | $0 |
| Other NC Liab. | $0 | -$240 | -$246 | $0 |
| Total NC Liab. | $2,694 | $2,115 | $1,275 | $714 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $257 | $262 | $266 | $0 |
| Total Liabilities | $5,003 | $4,207 | $3,307 | $2,406 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $7 | $7 | $7 |
| Retained Earnings | -$100,348 | -$98,992 | -$97,916 | -$96,786 |
| AOCI | $30 | $30 | $30 | $29 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$1,641 | -$522 | $523 | $1,597 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,362 | $3,685 | $3,830 | $4,003 |
| Net Debt | $1,728 | $1,157 | $619 | -$825 |